View |
|
DRP-3264-14
|
Paracetamol/ Vitamin B1/ Vitamin B6/ Vitamin B12
|
None
|
500 mg/50 mg/100 mg/100 mcg
|
Film-Coated Tablet
|
Analgesic
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
27 May 2024
|
20 May 2027
|
View |
|
DRP-3264-15
|
Paracetamol/ Vitamin B1/ Vitamin B6/ Vitamin B12
|
Pain B-Gan
|
500 mg/50 mg/100 mg/100 mcg
|
Film-Coated Tablet
|
Analgesic
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
27 May 2024
|
20 May 2027
|
View |
|
DRP-4838-10
|
Fenofibrate
|
Fenolizen
|
200 mg
|
Capsule
|
Lipid Modifying Agent (Fibrates)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
30 May 2024
|
16 October 2028
|
View |
|
DRP-5240-26
|
Ceftriaxone (as sodium)
|
Ceftratech
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Scott-Edil Advance Research Laboratories & Education Ltd
|
India
|
CLIDP Conversion
|
27 May 2024
|
07 April 2029
|
View |
|
DRP-5411-01
|
Fluticasone Propionate
|
Flutilon
|
500 mcg/mL (0.05% w/v) 50 mcg per actuation
|
Suspension for Nasal Spray
|
Corticosteroid
|
Norris Medicines Limited
|
India
|
Renewal
|
31 May 2024
|
01 August 2029
|
View |
|
DRP-5486-05
|
Albendazole
|
Albendix
|
400 mg
|
Chewable Tablet
|
Antihelmintic (Benzimidazole derivative)
|
Scott-Edil Pharmacia Limited
|
India
|
Renewal
|
29 September 2024
|
27 August 2029
|
View |
|
DRP-5683-25
|
Cefixime
|
None
|
20mg/mL
|
Granules for Suspension (Oral Drops)
|
Antibacterial
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
31 May 2024
|
20 February 2029
|
View |
|
DRP-6651-04
|
Rosuvastatin (as Calcium)
|
Rostar
|
5 mg
|
Film-Coated Tablet
|
Lipid Modifying Agent (HMG CoA Reductase Inhibitor)
|
Maple Pharmaceuticals (Pvt.) Ltd.
|
Pakistan
|
CLIDP Conversion
|
30 May 2024
|
22 April 2026
|
View |
|
DRP-6729-04
|
Risperidone
|
Risperi
|
2 mg
|
Tablet
|
Antipsychotic
|
LIFESQUARE LABORATORIES INC.
|
Philippines
|
CLIDP Conversion
|
24 May 2024
|
20 June 2029
|
View |
|
DRP-8747-03
|
Omeprazole (as sodium)
|
Promezol
|
40 mg
|
Lyophilized Powder for Intravenous Injection / Infusion
|
Proton Pump Inhibitor
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
30 May 2024
|
21 February 2025
|
View |
|
DRP-8859-01
|
Irinotecan Hydrochloride
|
Ventera
|
20 mg/mL
|
Solution for IV Infusion
|
Antineoplastic agent
|
Qilu Pharmaceutical Hainan Co., Ltd.
|
China
|
CLIDP Conversion
|
30 May 2024
|
02 July 2025
|
View |
|
DRP-9341-03
|
Ampicillin (as Sodium) + Sulbactam (as Sodium)
|
Haitam
|
500mg/250 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Penicillin) + Beta-lactamase Inhibitor
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
28 June 2024
|
11 March 2029
|
View |
|
DRP-15188
|
Iopamidol
|
Pamidol 300
|
612.4 mg/mL (Equivalent to 300 mg Iodine)
|
Solution
for Injection
|
Contrast Media
|
Unique Pharmaceutical Laboratories (A Division of
J.B. Chemicals & Pharmaceuticals Ltd.)
|
India
|
Initial
|
22 May 2024
|
22 May 2029
|
View |
|
DRP-15186
|
Ceftazidime (as pentahydrate) with sodium carbonate
|
Brizamide
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Third-Generation Cephalosporin)
|
Chengdu Brilliant Pharmaceutical Co., Ltd.
|
China
|
Initial
|
22 May 2024
|
22 May 2029
|
View |
|
DRP-15187
|
Ceftriaxone (as sodium)
|
Axonedu
|
500 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Third-generation Cephalosporin)
|
Chengdu Brilliant Pharmaceutical Co., Ltd.
|
China
|
Initial
|
22 May 2024
|
22 May 2029
|
View |
|
DRP-15189
|
Allopurinol
|
Urisol
|
100 mg
|
Tablet
|
Antigout
|
Centurion Laboratories Pvt. Ltd.
|
India
|
Initial
|
22 May 2024
|
22 May 2029
|
View |
|
DR-XY49088
|
Apixaban
|
Apiban 5
|
5 mg
|
Film-Coated Tablet
|
Antithrombotic Agent
|
MSN Laboratories Private Limited
|
India
|
Initial
|
22 May 2024
|
22 May 2029
|
View |
|
DR-XY49089
|
Trimetazidine dihydrochloride
|
Trimet PR-80
|
80 mg
|
Prolonged-Release Capsule
|
Anti-angina (Cardiac Preparation)
|
Globela Pharma Private Limited
|
India
|
Monitored Release (MR)
|
22 May 2024
|
22 May 2029
|
View |
|
DRP-15201
|
Rabeprazole sodium
|
Rabb-20
|
20 mg
|
Lyophilized Powder for Injection (I.V.)
|
Proton Pump Inhibitor
|
United Biotech Pvt. Ltd.
|
India
|
Initial
|
24 May 2024
|
24 May 2029
|
View |
|
DRP-15204
|
Enalapril maleate
|
Enaprinova-5
|
5 mg
|
Tablet
|
Angiotensin-converting Enzyme (ACE) Inhibitor
|
S Kant Healthcare Ltd.
|
India
|
Initial
|
24 May 2024
|
24 May 2029
|